We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+5.89%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+302.07%
AUM
$47.8B
AUM Growth
+$3.07B
(+6.9%)
Cap. Flow
-$507M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
17.74%
Holding
1,131
New
130
Increased
292
Reduced
306
Closed
143
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$526M |
| 2 |
Ally Financial
ALLY
|
+$198M |
| 3 |
CSX Corp
CSX
|
+$191M |
| 4 |
NetEase
NTES
|
+$173M |
| 5 |
Norwegian Cruise Line
NCLH
|
+$171M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$262M |
| 2 |
CVS Health
CVS
|
+$240M |
| 3 |
Mastercard
MA
|
+$204M |
| 4 |
McKesson
MCK
|
+$201M |
| 5 |
Molson Coors Class B
TAP
|
+$171M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Communication Services | 13.94% |
| 3 | Technology | 12.15% |
| 4 | Financials | 10.5% |
| 5 | Energy | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Teradyne
TER
$54.8B
| $120M | 0.25% |
6,120,489
+756,395
| +14% | +$14.1M |
|
|
CVD
102
DELISTED
COVANCE INC.
CVD
| $120M | 0.25% |
1,397,703
-80,700
| -5% | -$7.19M |
|
|
K
103
DELISTED
Kellanova
K
| $116M | 0.24% |
1,882,167
-1,328,497
| -41% | -$83.2M |
|
104
Check Point Software Technologies
CHKP
$13.3B
| $115M | 0.24% |
1,720,460
-1,966
| -0.1% | -$129K |
|
105
Unilever
UL
$131B
| $114M | 0.24% |
2,232,243
+99,948
| +5% | +$5.01M |
|
106
Madison Square Garden
MSGS
$9.54B
| $113M | 0.24% |
+2,529,850
| New | +$99.4M |
|
107
Rockwell Automation
ROK
$51.4B
| $112M | 0.23% |
893,427
-64,194
| -7% | -$7.91M |
|
108
Costco
COST
$415B
| $110M | 0.23% |
957,011
-63,600
| -6% | -$7.3M |
|
109
HF Sinclair
DINO
$15.9B
| $109M | 0.23% |
2,499,605
-2,783
| -0.1% | -$137K |
|
110
British American Tobacco
BTI
$132B
| $108M | 0.23% |
1,815,356
+1,766
| +0.1% | +$103K |
|
111
Aon
AON
$77.3B
| $107M | 0.22% |
+1,192,024
| New | +$103M |
|
112
Grupo Cibest SA
CIB
$20.4B
| $106M | 0.22% |
1,841,925
+54,123
| +3% | +$3.08M |
|
113
Banco Bradesco
BBD
$38.1B
| $106M | 0.22% |
18,670,364
+697,053
| +4% | +$4.07M |
|
|
TDF
114
Templeton Dragon Fund
TDF
$268M
| $106M | 0.22% |
4,098,617
-183,458
| -4% | -$4.57M |
|
115
NextEra Energy
NEE
$187B
| $105M | 0.22% |
4,100,340
-230,160
| -5% | -$5.6M |
|
116
Kohl's
KSS
$2.03B
| $101M | 0.21% |
1,909,738
+4,836
| +0.3% | +$262K |
|
117
O-I Glass
OI
$1.39B
| $99.9M | 0.21% |
2,882,546
+617,316
| +27% | +$20.4M |
|
118
Lloyds Banking Group
LYG
$87.4B
| $99.8M | 0.21% |
19,416,256
+2,957,708
| +18% | +$15.3M |
|
119
Sumitomo Mitsui Financial
SMFG
$166B
| $99.5M | 0.21% |
11,747,845
+99,197
| +0.9% | +$817K |
|
120
iShares Core US Aggregate Bond ETF
AGG
$138B
| – | – |
0
| – | – |
|
121
Bunge Global
BG
$23.6B
| $98.5M | 0.21% |
1,301,899
-72,900
| -5% | -$5.64M |
|
122
Voya Financial
VOYA
$8.94B
| $97.3M | 0.2% |
2,678,051
+2,677,689
| +739,693% | +$95.7M |
|
123
McDonald's
MCD
$188B
| $96.6M | 0.2% |
958,642
+553,003
| +136% | +$55.8M |
|
124
Edison International
EIX
$30.7B
| $96.5M | 0.2% |
1,660,485
+1,611,168
| +3,267% | +$90.2M |
|
125
American Airlines Group
AAL
$9.58B
| $94.8M | 0.2% |
2,205,844
-426,220
| -16% | -$16.6M |
|
Similar funds
QCM
Lazard Asset Management's Q2 2014 Portfolio in Review
As of Q2 2014, Lazard Asset Management held 1,131 positions worth $47.8B, up 6.9% from $44.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Lazard Asset Management's Q2 2014 filing shows 130 new, 292 increased, 306 reduced and 143 closed positions. Its largest new stake was Ally Financial: 8,153,883 shares worth $195M. The largest sale was Gilead Sciences, an estimated $262M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Communication Services and Technology.
- Lazard Asset Management's largest Q2 2014 buy was Ally Financial: 8,153,883 shares worth $195M.
- Lazard Asset Management added most to Teva Pharmaceuticals in Q2 2014, an estimated $526M increase.
- Lazard Asset Management's biggest Q2 2014 reduction was Gilead Sciences, cutting an estimated $262M.
- Lazard Asset Management fully exited Mastercard in Q2 2014, selling an estimated $204M.
- Lazard Asset Management's ten largest holdings make up 18% of its $47.8B portfolio in Q2 2014.
- Lazard Asset Management opened 130 new positions and closed 143 in Q2 2014.
- Lazard Asset Management's portfolio value rose 6.9% quarter-over-quarter to $47.8B.
Based on Lazard Asset Management's 13F filing for Q2 2014, filed 12 Aug 2014.